“Injury Prevention & Control: Opioid Overdose,” Centers for Disease Control and Prevention. www.cdc.gov/drugoverdose/index.html (Last accessed March16, 2016).
2.
BrueraE, PaiceJA: Cancer pain management: Safe and effective use of opioids. Am Soc Clin Oncol Educ Book, 2015; 35:e593–e599.
3.
BohnertASB, ValensteinM, BairMJ, et al.: Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA, 2011; 305:1315–1321.
4.
ChwistekM, EwerthN: Opioids and chronic pain in cancer survivors: Evolving practice for palliative care clinics. J Palliat Med, 2016; 19:19111.
5.
TanPD, BarclayJS, BlackhallLJ: Do palliative care clinics screen for substance abuse and diversion? Results of a National Survey. J Palliat Med, 2015; 18:752–757.
6.
MuellerSR, et al.: A review of opioid overdose prevention and naloxone prescribing: Implications for translating community programming into clinical practice. Substance Abuse, 2016; 36:240–253.
OlivaEM, NevedalA, LewisET, et al.: Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs. Subst Abus, 2016; 37:118–126.
9.
Naloxone (Narcan) nasal spray for opioid overdose. Med Lett Drugs Ther, 2016; 58:1–2.
10.
MerlinMA, SayboltM, KapitanyanR, et al.: Intranasal naloxone delivery is an alternative to intravenous naloxone for opioid overdoses. Am J Emerg Med, 2010; 28:296–303.
11.
DowellD, HaegerichTM, ChouR: CDC Guideline for prescribing opioids for chronic pain—United States, 2016. JAMA, 2016; 315:1624–1645.
12.
BohnertAS, ValensteinM, BairMJ, et al.: Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA, 2011; 305:1315–1321.
13.
DunnKM, SaundersKW, RutterCM, et al.: Opioid prescriptions for chronic pain and overdose: A cohort study. Ann Intern Med, 2010; 152:85–92.
14.
WalleyAY, Doe-SimkinsM, QuinnE, et al.: Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat, 2013; 44:241–247.
15.
HallAJ, LoganJE, ToblinRL, et al.: Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA, 2008; 300:2613–2620
16.
CoffinPO, TracyM, BucciarelliA, et al.: Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med, 2007; 14:616–623.
17.
EvansJL, TsuiJI, HahnJA, et al.: Mortality among young injection drug users in San Francisco: A 10-year follow-up of the UFO study. Am J Epidemiol, 2012; 175:302–308.
18.
BinswangerIA, SternMF, DeyoRA, et al.: Release from prison—A high risk of death for former inmates. N Engl J Med, 2007; 356:157–165.
